MACROPHAGE-ACTIVATING COMPOSITION AND A PROCESS FOR ITS MANUFACTURE

Abstract: Macrophage-stimulatory composition containing a wat­ er-insoluble β-1.3-bound glucan and a water-soluble carrier to which the glucan has been immobilized; its use; and a process for its manufacture.

Description: The present invention relates to a macrophage-activating composition containing a water-soluble β-1.3-bound D-glucan and a water-insoluble carrier on which said glucan is immobilized. A water-soluble glucan immobilized in this manner has in connection with the invention been found to possess capability of acitvating mononuclear phagocytes, so called macrophages. It is known that certain polysaccharides improve the defence mechanism of the body, i.a. through activation of the complement system and stimulation of the function of monocytes- macrophages. These cells are of a central importance to the defence of the body, both from the inside and from the outside, for example against the growth of cancer cells or the attack of for example bacteria. It has been previously shown (GLYCAN STIMULATION OF MACROPHAGES IN VITRO, R. Seljelid, G. Bögwald and Å.Lundwall, Experimental Cell Research 139 (1981) 121), that certain and necessarily non-soluble glucans, particularly such containing 1.3-bound β-D-glucose entitities, activate macrophages in vitro and make same cytotoxic. Since unsoluble compounds often are unsuitable to use in vitro and in vivo the main object of the invention is to provide a composition having the ability of providing activation of macrophages making it possible to obtain controlled conditions. Another object of the invention is to provide a process for the manufacture of such composition. In accordance with the present invention it has been surprisingly found that water-soluble β-1.3-bound D-glucans which normally do not activate macrophages by immobilization to a water-insoluble carrier obtain macrophage-stimulating properties. Soluble, per se inactive β-1.3-bound D-glucans thus activate macrophages after immobilization to suitable surfaces. Such surfaces find broad utility in medicinal technology. As examples there may be mentioned different forms of extracorporeal circulation, where blood is passed over surfaces coated with β-1.3-bound D-glucans. Other medicinal applications are presented in the following in the exemplifying part of the disclosure. As examples of β-1.3-bound D-glucans useful in the present invention there may be mentioned laminaran, curdlan, pachyman, yeast glucan and lichenan. By the expression "macrophage as used in the present disclosure is meant mononuclear phagocytes which is a more adequate expression from a scientific point of view. The tehnique according to the present invention may thus primarily be used for activating mononuclear phagocytes of animals including man. This means that the composition according to the present invention can be used for improving the body defence of animals, for example against infections and cancer, particularly humans and commercially useful animals. Such conceivable areas of use are verified by the experimental tests which are presented in the following in the present disclosure. The immobilization of the glucan is preferably provided by covalent coupling to a suitable carrier. Particularly preferred is the use of carriers containing amino groups to which the glucan is coupled. The preferred technique thus means that the surface of the carrier is first activated by introduction of amino groups. The glucan is modified in such a manner as to be covalently bindable to the aminated surface. The character of the carrier is not critical and the use of different types of plastics is conceivable as well as the use of aminated gels. The technique for covalent coupling of a glucan to a surface while using binding to amine groups is, as previously indicated, a preferred technique for immobilization. As example a β-1.3-bound D-glucan is degraded in a suitable acid, preferably a strong acid, for example formic acid, and is then treated with 2-chloracetaldehydodimethylacetal for substitution with O-(2.2'-dimethoxyethyl)-groups. Such substituted glucan is then treated with acid to form aldehyde groups, the aldehyde-substituted glucan being then brought into contact with a carrier containing amino groups in the presence of cyanoborohydride, covalent coupling to the carrier being provided. In another example epoxyfunctions are introduced in a glucan by activation with epichlorohydrin. When the epoxi-activated glucan is brought into contact with a carrier containing amino groups these latter react with the epoxy groups, the glucan being covalently bound to the carrier. Details concerning the coupling technique is clear from the following specific examples. Reverting to the application of the invention it has been found that in accordance with the invention immobilized β-1.3-bound D-glucans show cytostatic effect and antibacterial effect. The fact that immobilized β-1.3-bound D-glucans activate macrophages so that they provide for a cytostatic effect is shown in the present disclosure by the use of tumor cells and macrophages in culture on tissue cultivating plates covered with β-1.3-bound D-glucans. The results are presented below in the examples. The fact that immobilized β-1.3-bound macrophages possess antibacterial activity is shown in the disclosure by the fact that β-1.3-bound D-glucans coupled to polystyrene spheres prevent peritonitis in mice infected with pneumococci or streptococci. The results in connection hereto are unambiguous in that all test animals in the control group died, whereas all animals treated with glucan-coated polystyrene spheres survived. The invention also provides for a macrophage-stimulatory composition containing as an active constituent an immobilized glucan according to the invention in combination with a pharmaceutically acceptable carrier. The active immobilized glucans according to the present invention can, in a conventional manner, be formulated for use in human or veterinary medicine. The composition or the pharmaceutical preparation can contain the active constituents in combination with a pharmaceutically acceptable carrier which may be solid, semi-solid or liquid depending on the route of administration and other actual conditions. Sometimes it may also be suitable to use a bio-degradable carrier. The active constituents may also be used as such without the addition of carrier materials. The compositions are manufactured in full conformity with conventional pharmaceutical practice. As previously indicated the function of the mononuclear phagocytes is of a central importance to the defence of the body both in influence from the inside and from the outside. Through the present invention compositions are made available which have the ability of generally activating the defence system of the body, for example against growth of cancer cells and infections. Such applications are conceivable for vertebrate animals of different kinds , comprising mammals including man and fishes. In order to reduce the tendency for arisal of diseases in for example fish cultivated under controlled conditions the compositions according to the present invention may advantageously be supplied to the fish milieu, either directly in the water where cultivation is carried out or as an additive to the food. The invention is particularly useful in connection with cultivation of noble fish, such as salmon, trout or similar species. The invention will in the following be further described by specific examples. The description is made in connection with the appended drawing, wherein Fig. 1 shows in the form of columns stimulatory index for some plastic surfaces; Fig. 2 shows introduction of L-929 cells in co-cultivation with macrophages grown on different plastic surfaces. BIOLOGICAL METHOLOGY Macrophage cultures Peritoneal cells from hybride C₃D₂ (C3H/Tifx x DBA/2) mice (7 x 10⁵ cells/well) were transferred onto covering glasses (diameter 14 mm) of circular wells in Costar tissue culture plates (Costar, Cambridge, Mass. USA). After two hours in culture cells which had not adhered to the bottom of the well were washed off. The cells were cultured in Eagle's medium with Earle's salts (DME) (Gibco Biocult Ltd. 3 Washington Road, Paisley, Scotland) in 5% v/v CO₂ in air at 37 o C with or without addition of serum. All media contained penicillin (100 I.U./ml) and streptomycine (100 µg/ml). Scanning electron microscopy (SEM) Macrophage cultures were fixed in 2.5% glutaraldehyde (Merck) in 0.1 M cacodylat buffer pH 7.3 and 0.1 M sucrose. The cells were dehydrated in increasing concentrations of ethanol critical point dried in (Hitachi, CPI, Tokyo, Japan) carbon dioxide. The preparations were mounted, covered with gold (Polaron SEM Coating Unit E 5000) and analyzed in a Hitachi SEM (HHS12R) with 20 kV and a tilt angle of 15 o . The pictures were taken on Kodak tri-X pan (TX P-120) film. Animals In the experiments using B16 melanoma inbread C₅₇BL mice were used. In the rest of the studies the macrophages were obtained from hybrid C₃D₂ (C₃H Tif x DBA/2) mice. All animals were obtained from Gl. Bomholtgård Ltd. Ry, Denmark. CHEMICAL METHOLOGY Curdlan was obtained from Wako Pure Chemical Industries, Osaka, Japan, amylosetype III from Sigma, St.Louis, USA, laminaran from United States Biochemical Corp., Cleveland, USA, polymeric aminocompounds Polymin SN® and Polymin P® from BASF, Ludwigshafen, West Germany. Aminated polystyrene spheres were obtained from Uglestad, Norway and aminated plates from Falcon. The other chemicals were obtained from Merck, Darmstadt, West Germany. Sugar analysis Substances containing the relevant carbohydrates (10 mg) were treated together with internal standard ( myo -inositol, 1 mg) with trifluoro acetic acid (0.5 M, 2 ml) for 12 hours at 100 o C, neutralized (BaCO₃) filtered and reduced (NaBH₄, 10 mg). After 2 hours pH was adjusted to about 5 using an acid ion exchange (Dowex 50) and the sample was filtrated and evaporated into dryness together with methanol. The sample was acetylated using acetic acid anhydride (1 ml) and pyridine (1 ml) for 15 minutes and at 100 o C. The sample was evaporated into dryness and analysed by gaschromotography. EXAMPLE 1, Modification of glucanes by introducing aldehyde function. Curdlan, which is a water-insoluble β-1.3-bound D-glucan was degraded in formic acid (90% aq) at 90 o C for 20 minutes according to K. Ogawa, I.Tsurugi and T.Natanabe, The dependence of the conformation of a (1→3)-β-D-glucan on chain length in alkaline solution, Carbohydr.Res. 29 (1973) 397. The partially degraded curdlan was then separated into a water-soluble and a water-insoluble fraction. The water-soluble fraction was reduced using sodium borohydride (10 mg/g) in aqueous solution, dialyzed and freeze-dried. The water-soluble curdlan fraction, laminaran (a water-soluble β-1.3-bound D-glucan), amylose (a water-soluble α-1.4-bound D-glucan) were alkylated according to S.Hakomori, A rapid permethylation of glucolipid and polysaccharide catalyzed by metylsulfinyl carbanion in dimethylsulfoxide, J.Biochem., (Tokyo) 55 (1964) 205. The polysaccharide (0.5 g) was dissolved in dry dimethylsulfoxide (20 ml) in a serum bottle under nitrogen gas. Using an injection syringe 2M sodiummethylsulfinylmethanide (8 ml) were added. After agitation in an ultrasonic bath at 50 o C for 30 minutes the reaction mixture was allowed to stand at room temperature over night. 2-chloracetaldehydedimethylacetal (5 ml) was added gradually using a syringe. After agitation in the ultrasonic bath at 50 o C for 60 minutes the reaction mixture was poured into water and dialyzed against distilled water. Freeze-drying yielded about 0.45 g of glucan substituted with 0-(2.2¹-dimethoxyethyl)-groups. The degree of substitution was determinted by ¹H-n.m.r. The first step of the reaction is illustrated below. Amylose, partially degraded curdlan and laminaran had on average 0.7, 0.5 and 0.4 0-(2.2¹-dimethoxyethyl)groups, respectively, on each monomer glucose entity. H-n.m.r. spectra were run at 90 MHz in D₂O at 85 o C in a Jeol FX 90 Q n.m.r. instrument. The O-(2.2¹-dimethoxyethyl)substituted glucan (0.4 g) was treated with hydrochloric acid (25 ml, 0.05 M) at 100 o C for 20 minutes, neutralized (0.5 M NaOH), dialyzed against distilled water and freeze- dried. The yield was 0.35 g polysaccharide substituted with aldehyde groups. The second step of the reaction can be illustrated as follows: EXAMPLE 2, Modification of glucans by introducing an epoxi-function Laminaran (5 g) was dissolved in 60 ml destilled water. Epichlorohydrine (10 ml), 2 M sodiumhydroxide solution aq (30 ml) and sodiumborohydride (200 mg) were added. The mixture was allowed to stand under stirring at room temperature over night, dialyzed against acetic acid (10%, 1 liter) and distilled water (5 l) evaporated to a smaller volume (50 ml) and freeze-dried. The yield of epoxi-activated laminaran 4.5 g. The reaction is illustrated below: EXAMPLE 3, Periodate oxidation of amylose. Amylose is a linear α-1.4-bound D-glucan which is oxidized by periodate (NaIO₄) as follows. Amylose (16.2 g) is dissolved in water (200 ml) and then a solution of NaIO₄ (2.0 g) in water (50 ml) is added. The solution thus obtained is allowed to stand over night under stirring. The material is dialyzed and freeze-dried. Yield 14.5 g. The reaction is illustrated below: EXAMPLE 4, Sulfatization of amylose . Amylose (0.5 g) is dissolved in dimethylsulfoxide (4 ml). A sulfurtrioxide-pyridine complex (3 g) is added and the mixture is stirred at 40 o C for 60 minutes. Crushed ice is added (10 g) and water (5 ml). The mixture is then neutralized to pH 7 using sodiumhydroxide (2 M). The product is precipitated in ethanole, dialyzed and freeze-dried. Yield 0.4 g. EXAMPLE 5, Modification of plastic surfaces . An aqueous solution of Polymin SN® (0.005%, w/w) and periodateoxidized amylose (0.5%, w/w) prepared as in example 3 are adjusted to pH 9 (1M NaOH) and added to each well in a plate for tissue cultivation. The wells are washed with distilled water, and an aqueous solution of amylose sulfate (0.02%, w/w, pH 3) prepared as in Example 4 is added at 50 o C. After 5 minutes the wells are washed with water. The procedure is repeated twice, and after the last addition of amylose sulfate there is added a 0.01% aqueous solution of Polymin SN® at pH 3. After 5 minutes the wells are washed with distilled water. EXAMPLE 6, Coupling of aldehydoglucan according to Example 1 to plate for tissue cultivation modified according to Example 5 . Glucan (4 mg) substituted with aldehydegroups, prepared as per Example 1 is dissolved in 2 ml of phosphate buffer (ph 7.0, 0.2 M). To each well of the plate for tissue cultivation according to Example 5 there is added the glucan solution (0.1 ml, 0.1 M), phosphate buffer (2.6 ml, pH 7.0) and sodiumcyanoborohydride (100 µg). The plates are allowed to stand at room temperature overnight, are washed with distilled water and dried at room temperature. Sugar analysis showed that 0.01 mg glucan had been bound to each well. The coupling sequence is diagramatically shown below: EXAMPLE 7, Coupling of aldehydoglucan according to Example 1 to aminated polystyrene plates. Glucan (4 mg) substituted with aldehyde groups according to Example 1 is coupled to the wells of commercially aminated polystyrene plates for tissue cultivation according to Example 6. (Falcon® 3847 PRIMARIA CULTURE PLATES). Sugar analysis showed that ∼0.005 mg glucan was bound to each well. EXAMPLE 8, Coupling of aldehydoglucan according to Example 1 to aminated polymethacrylate spheres . Glucan (4 mg) substituted with aldehyde groups according to Example 1 is dissolved in 25 ml phosphate buffer (pH 7.0, 0.2M). To this solution there are added aminated plastic spheres (0.2 g) having a diameter of 2.4 µm manufactured by copolymerization of 2.3-epoxipropylmethacrylate and ethylenglycoldimethacrylate according to J.Uglestad, P.C.Mörk, K.M.Kaggerud, T.Ellingsen and A.Berge SWELLING OF OLIGOMER-POLYMER PARTICLES. NEW METHODS OF PREPARATION OF EMULSIONS AND POLYMER DISPERSIONS. Adv . Colloid Interface Sci . 13 (1980) 101. In addition there is added sodiumcyanoborohydride (0.005g). The reaction mixture is shaken at room temperature over night, is filtered on glass filter and washed repeatedly with distilled water. The spheres are airdried at room temperature. EXAMPLE 9, Coupling of epoxiglucan according to Example 2 to plastic surfaces according to Example 5. A 1% solution of epoxi-activated laminaran prepared as per Example 2 was dissolved in phosphate buffer (0.2 M, pH 7.0) and added to each well of a plate for tissue cultivation modified as per Example 5. The plates were allowed to stand at room temperature over night, were washed with distilled water and dried at room temperature. Sugar analysis showed that 0.005 mg glucan had been bound to each well. The reaction for the coupling is illustrated diagramatically below: EXAMPLE 10, Stimulation of macrophages with surfaces covered with immobilized glucans according to Examples 6, 7 and 9 . ¹⁴C-labelled D-glucoseamine is added to macrophage cultures in wells of tissue cultivation plates with and without immobilized β-1.3-bound D-glucan. An increased incorporation of D-glucoseamine in glycoproteins in macrophages is an activation parameter for macrophages. After 24 hours the cells are dissolved in 5% trichloroacetic acid and non-incorporated radioactive D-glucoseamine is washed away. The washed cells are dissolved in sodiumhydroxide (1M). When all cell material has been dissolved the solution is transferred to measuring cuvettes and the radioactivity is measured in a scintillation counter. The degree of activation is expressed by the quotient: The best results are obtained from plates activated accordind to Example 6. The results are presented in Fig. 1 which will be explained below. EXAMPLE 11. Cytostatic effect of macrophages activated on plates for tissue cultivation covered with β-1.3-bound D-glucans . Target cells (2 x 10⁴ cells/well) were treated with trypsine and added to the macrophages cultures in the presence of glucan-covered plastic surfaces according to Examples 6, 7 and 9. After different times there were added 0.5 µCi/ml radioactive thymidine (methyl - ³H, New England Nuclear, Dreieich, West Germany) to the cultures. Incorporation was measured after an incubation period of 24 hours. After harvesting the cultures the high-molecular material was precipitated with 1M perchloric acid and thouroghly washed before dissolution in 1M sodiumhydroxide solution. The dissolved material was transferred to measuring cells and analyzed in a scintillation counter (Packard Instruments, International, Zürich, Switzerland). The best results were obtained from plates modified according to Example 6. The others gave acceptable results. The results are shown in Fig. 2 which is explained below. EXAMPLE 12. Experiments relating to antibacterial effect . For investigating the antibacterial effect in vivo 10⁶ virulent pneumococci were injected interperitoneally on mice which had been pretreated with either β-1.3-bound glucancovered polymethacrylate spheres according to Example 8 or saline. In the saline group (4 animals) all mice became sick after 24 hours and died after 48 hours, whereas in the glucan-treated group (8animals) none of the animals showed any visible symptoms of disease and none of them had died one week later. The experiment was repeated while injecting virulent Streptococcus Viridans and with polymethacrylate spheres treated with β-1.3-bound D-glucans, and the animals showed no signs of disease. The experiments have been repeated three times with the same result. The degree of stimulation of macrophages determined by morphology (SEM) introduction of ¹⁴C-glucoseamine and by cytostatic effect on target cells of the type L-929. Macrophages grown on aminated plastic (microtiterplate according to Example 5) or plastic with immobilized amylose incorporated somewhat more ¹⁴C-glucoseamine than cells grown on untreated plastic. However, a ten-fold increase in incorporation of ¹⁴C-glucoseamine was obtained when macrophages were grown on surfaces containing immobilized laminaran or curdlan. This fact is clear from appended Fig. 1 showing the introduction of radioactive ¹⁴C-glucoseamine in macrophages, cultivated for 48 hours on microtiterplates of modified plastic. In Fig. 1 stimulatory index relates to introduction (cpm) in stimulated macrophages divided by introduction in normal unstimulated macrophages . In the Fig. column 1 relates to aminated plastic, column 2 relates to plastic with immobilized amylose, whereas columns 3 and 4 relate to plastic with immobilized curdlan and immobilized laminaran, respectively, where coupling of the glucan is carried out according to Example 5. The results in the figure relate to average ± standard deviation. As is clear from Fig. 1 using the technique of the present invention results in a substantial increase of the stimulation of the macrophages . The cytostatic effect of macrophages was studied by measuring the introduction of radioactive ³H-thymidine in L-929-cells with co-cultivation. Unstimulated macrophages have a certain cytostatic effect on L-929-cells, and in a typical experiment cultivation of solely L-929-cells incorporated about 55 000 cpm. In the presence of unstimulated macrophages a corresponding cultivation of L-929-cells incorporated about 15 000 cpm. 100% in Fig. 2 L-929-cells in co-cultivation with macrophages on aminated plastic incorporated about 50% less of ³H-thymidine than L-929-cells in co-cultivation using unstipulated macrophages. This is illustrated in appended Fig. 2, wherein the introduction of radioactive thymidine is shown for a number of cultures of L-929-cells with macrophages . Column 1 shows cultivation in plates of unmodified plastic, column 2 shows the corresponding cultivation carried out in plates of aminated plastic, whereas columns 3, 4 and 5 show cultivation performed in plates of plastic with immobilized amylose, curdlan and laminaran, respectively. Application of the technique according to the invention obviously results in a drastically growth-inhibiting effect by the stimulation provided by the macrophages .

Claims: Macrophage-stimulatory composition containing a water-soluble β-1.3-bound glucan and a water-insoluble carrier on which the glucan has been immobilized. Composition according to claim 1, wherein the glucan is selected from water-soluble fractions of laminaran, curdlan, pachyman, yeast glucan and lichenan. Composition according to claim 1 or 2, wherein the glucan is a water-soluble curdlan or laminaran. Composition according to claim 1 for use in activating mononuclear phagocytes. Composition according to any of claims 1 to 3 for use for inhibiting the growth of cancer cells. Composition according to claim 1 characterized thereby that the glucan is covalently coupled to the carrier. Composition according to claim 5, characterized thereby that the carrier contains amino groups to which the glucan is coupled. Composition according to claim 1 for use in improving the body defense of animals, particularly humans and commercially utilizable animals. Composition according to claim 1, characterized thereby that the carrier consists of a plastic, an aminated gel or a protein. A process for the manufacture of a composition according to claim 1, characterized in that an insoluble β-1.3-bound glucan is degraded in acid and thereby dissolved and is then treated with 2-chloroacetaldehydedimethylacetal for substitution with the 0-(2.2'-dimethoxyethyl)group, and that the substituted glucan is treated with acid to form aldehyde substitution, the resulting water-soluble aldehyde-substituted glucan being then brought into contact with a carrier containing amino groups in the presence of cyanoborohydride resulting in covalent coupling to the carrier.

Inventors: BOGWALD, JARL, HOFFMAN, JAMES, LARM, KARL OLOV PETER, SELJELID, ROLF
Applicants: BOGWALD, JARL, HOFFMAN, JAMES, LARM, KARL OLOV PETER, SELJELID, ROLF
Application year: 1985
Main classification: A61K31
IPC codes: A61K47, A61K31, A61P37, C12N9